CapDecisif Management

About The Fund

CapDecisif Management, known as Karista since its rebranding, is a Paris-based venture capital firm that was established in 2001. They specialize in investing in innovative companies within the realms of Health, Digital, Tech, and NewSpace. Their investment focus ranges across various stages, including Seed, Startup, Early Stage, and Expansion phases. With a fund expertise in Equity, they cater to a vast array of industries such as BioTech, HealthTech, CleanTech, IT, IoT, Material Science, Medical Devices, Aerospace, and more. The firm has a substantial minimum investment threshold of 200,000 euros and can invest up to 30 million euros. They manage assets worth approximately 175 million euros. Karista takes pride in often being the first investor onboard and typically leads funding rounds at both early and growth stages. They aim to support companies that have the potential for global impact and are game changers in their respective fields. Over the past two decades, they have funded more than 100 companies, providing more than just capital by leveraging their extensive network to foster introductions and partnerships that can fuel their portfolio companies' growth. These companies range from those providing solutions for medical imaging and robotics to those offering aerospace services and cyber threat intelligence solutions. They have a robust portfolio, with investments in various sectors and support for companies through strategic insights and board involvement, immensely contributing to their companies' success and advancements. The leadership of Karista is deeply committed to fostering enduring relationships founded on trust and a shared ambition for remarkable outcomes. The fund also emphasizes the importance of aligning an investor's values with the company's culture, showing their dedication not only to the financial aspects of ventures but also to the human and strategic sides of business growth.